| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |